Kitadate A, Kobayashi H, Abe Y, Narita K, Miura D, Takeuchi M, Matsue K. Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients. Haematologica [Internet]. 2020Jan.1 [cited 2026Nov.5];105(1):e37-e40. Available from: https://haematologica.org/article/view/9503